CBR International

CBR International effectively assists small and medium-sized biotechnology and pharmaceutical companies in understanding FDA requirements and implementing cost-effective, scientifically robust product development plans. Since then, CBR has grown from a company with six consultants, focusing on U.S. regulatory and CMC issues, into a firm comprising 30-45 professionals engaged in quality, science, regulatory, and clinical affairs.